A great ESCRS experience with over 13.000 participants between 16-20th of September in Milan, Italy.

This year’s ESCRS Congress has been a great milestone for VSY Biotechnology with the release of first clinical outcomes of Acriva^UD Trinova Pro C Pupil Adaptive^® during satellite symposium and we searched for the sweet spot regarding material properties, several meetings and enjoyable gatherings with ophthalmologists and customers from all over the world

The first gold sponsor of 2022 ESCRS iNovation® Day 

We hold Gold Sponsorship of the very first #iNovationDay which is a first-of-its-kind event marking a new annual tradition in the society’s community and participated in the discussions for future of innovation in ophthalmology for the next 5 years.

For more details about the event, please visit: https://bit.ly/3Ck7QwM

Proud to be a Gold sponsor for ESCRS’s sustainability movement: “Mission Zero” 

We also accompanied the society’s #MissionZero commitment with our sustainability sponsorship to make an even bigger impact on our social and environmental future. This partnership is crucial for us as becoming an active participant who takes care of their environment and will inspire others to do the same.

Satellite symposium on our latest innovation: Acriva^UD Trinova Pro C Pupil Adaptive^® 

Last year’s ESCRS we launched the first and only trifocal presbyopia-correcting (PC-IOL) intraocular lens with patented enhanced sinusoidal vision technology: The Acriva^UD Trinova Pro C Pupil Adaptive^®. After a year from the launch, we were really excited to share the first clinical outcomes of The Golden Ratio in IOL Technology concept with the industry.

At the 3rd day of the congress on 18th of September, well-recognized surgeons Prof. Dr. Ike Ahmed, Prof. Dr. med. Gerd U. Auffarth FEBO, Dr. Karsten Klabe and Dr. Ramon Ruiz Mesa shared their experiences under the subject of “The Golden Ratio in IOL Technology and how “redefined diffraction” with the unique trifocal IOL - AcrivaUD Trinova Pro C Pupil Adaptive affects first clinical outcomes.” This symposium was one of most memorable and soundproof sessions for us and ophthalmology community during the congress.

To find out more about our satellite symposium and why “rethinking diffraction” with the Acriva Trinova Pro IOL:https://bit.ly/3CLnQcn

Podium debate on Hydrophobic or Hydrophilic IOL 

People who visited our booth witnessed a remarkable live debate to find out how modern IOL material makes a difference from well-recognized surgeons face-to-face. Assoc. Dr. Basak Bostancı and Dr. Florian Tobias Alwin Dr. med. Kretz discussed and shared their invaluable evidences on the topic of the differences between Hydrophobic & Hydrophilic IOL materials, under ESCRS president Prof. Dr. Oliver Findl's moderation.

We also appreciated for contribution of our partners from all over the world during our distributor event.

Yet, there’s still so much more we’ve got planned for next year.

We are already looking forward to meeting you at #ESCRS2023 in Vienna, Austria!